Apparently Chad Mendes’ positive drug test was triggered by a cream used to treat a skin condition, a source close to Mendes told BloodyElbow.com.
According to the source, who wished to remain anonymous, Mendes used the cream without knowing it contained GHRP-6.
Mendes was suspended two years yesterday for testing positive for the substance in an out-of-competition test administered back in May.
“I didn't do my homework and that was a big mistake,” Mendes tweeted last month. “I own it and I'm going to pay for it.”
Champions contributor and noted explainer on the matter of PED violations Ian Kidd wrote in another BloodyElbow.com article, "GHRP-6 stands for Growth Hormone Releasing Hexapeptide, and is one of a class of drugs known as growth hormone releasing peptides. Something to note is that while it has growth hormone in the name, GHRP-6 is not the same as human growth hormone (hGH).
"GHRP-6 is a substance which is designed to increase your body’s natural production of growth hormone. Much like clomiphene is useful for increasing the body’s production of testosterone, GHRP-6 does the same thing for growth hormone, though in a different way. GHRP-6 can be used as needed without requiring any "cycling" or post-cycle therapy."
Mendes will be eligible to fight again June 10, 2018. His last bout in the UFC saw him lose to Frankie Edgar at the TUF 22 Finale in December of 2015. The loss was his second in a row and third in his last four fights.
(Photo by Amy Kaplan)